Abstract
A series of structurally diverse 4-bromo spiro-isoxazolines possessing a variety of aromatic and aliphatic substituents at the 3 position, were synthesized through a 1,3-dipolar cycloaddition followed by intramolecular cyclization of a pendant hydroxyl or carboxylic acid group. The biochemical antiproliferative activity was evaluated in vitro by using two breast cancer cell lines (MCF-7 and MDA-MB-231) and two prostate cancer cell lines (PC-3 and DU-145) using the MTT viability assay, and the IC50 values were obtained. Spiro-isoxazoline derivatives bearing a p-chloro or an o-dichloro aromatic substituent at the 3-position of the isoxazoline showed considerable antitumor activities in all four cell lines with IC50 values ranging from 43 μM to 56 μM.
| Original language | English |
|---|---|
| Pages (from-to) | 1794-1797 |
| Number of pages | 4 |
| Journal | Tetrahedron Letters |
| Volume | 56 |
| Issue number | 14 |
| DOIs | |
| Publication status | Published - 1 Apr 2015 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 1,3-Dipolar cycloaddition
- Bioevaluation
- Regioselectivity
- Spiro-isoxazolines
- Stereoselective intramolecular cyclization
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Synthesis and investigation of novel spiro-isoxazolines as anti-cancer agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver